Building trust in AI for routine radiology use: what we heard at ECR 2022

The need to demystify AI in radiology applications was one of our key takeaways from ECR 2022. Read about some of the discussions and other themes in this blog post from Peter Ngum, Combinostics Clinical Application Specialist, and Greg Kingston, Combinostics Chief Marketing Officer (CMO).

Continue ReadingBuilding trust in AI for routine radiology use: what we heard at ECR 2022

Combinostics’ cDSI and cMRI Applications, Part of the cNeuro Platform, Receive EC-certification Under the EU’s Medical Device Regulation (MDR)

cNeuro® cDSI™ and cNeuro cMRI™ achieve EC-certification under MDR, ensuring continued delivery of services to European customers.

Continue ReadingCombinostics’ cDSI and cMRI Applications, Part of the cNeuro Platform, Receive EC-certification Under the EU’s Medical Device Regulation (MDR)

Slicing through the fog of neurodegeneration with cutting-edge tools: feedback from ASNR22

ASNR22 provided a great opportunity to discuss tools that would help neuroradiologists support their referring clinicians when diagnosing patients with symptoms of dementia. Read key takeaways from Peter Ngum, Combinostics Clinical Application Specialist, and Greg Kingston, Combinostics Chief Marketing Officer (CMO).

Continue ReadingSlicing through the fog of neurodegeneration with cutting-edge tools: feedback from ASNR22

Preserving the mind: key takeaways from AAN 2022

AAN 2022 highlighted cutting-edge research in neurology and provided opportunities for networking within the neurology community. Read key takeaways from Peter Ngum, Combinostics Clinical Application Specialist, from advances for traumatic brain injury to the future of AI and neurology.

Continue ReadingPreserving the mind: key takeaways from AAN 2022